7 Forbidden Words: Reports About Language Policy at CDC Stirs Controversy, Concern

On December 15 the Washington Post published a story about an alleged word ban at the Centers for Disease Control and Prevention (CDC).  The report was that the Trump administration was prohibiting officials at the nation’s top public health agency from using a list of seven words or phrases in official documents being prepared for next year’s budget.  The list of words was: “vulnerable,” “entitlement,” “diversity,” “transgender,” “fetus,” “evidence-based,” and “science-based.”

The news spread like wildfire on social media and cable news. Rumors circulated that the “ban” was throughout the Department of Health and Human Services (HHS). At the same time, however, CDC Director Dr. Brenda Fitzgerald refuted the story, and the Washington Post updated its original story, noting new developments and nuances and an official statement from HHS:

“HHS and its agencies have not banned, prohibited or forbidden employees from using certain words. Recent media reports appear to be based on confusion that arose when employees misconstrued guidelines provided during routine discussions on the annual budget process. It was clearly stated to those involved in the discussions that the science should always drive the narrative. Any suggestion otherwise is simply not true.”

The Endocrine Society was deeply concerned about the report, but noted equally as important is how much we invest in public health and the continued shortchanging of public health by lawmakers both in Congress and the administration.  For example, lawmakers have not yet agreed on a deal to raise austere spending caps, as the January 19 deadline to enforce sequestration’s across-the-board cuts looms, finalized FY 2018 funding for HHS, nor agreed on how to extend funding for the Children’s Health Insurance Program, Special Diabetes Program, community health centers, or the National Health Service Corps.

The Endocrine Society encouraged Congress to look into this issue and multiple representatives and senators sent letters to HHS to understand the facts of the story. The Society will continue to advocate for CDC and funding for the Prevention and Public Health Fund and will keep our members apprised of the situation.

 

You may also like

  • NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

    On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1…

  • Special Diabetes Program In Jeopardy; Congress Needs to Hear from You

    As Congress readies itself for the next federal budget deadline (February 8), funding for the Special Diabetes Program (SDP) remains uncertain. A top priority for the Endocrine Society is funding the SDP, which includes the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and…

Find more in